Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TPEX/1781 stock hub

TPEX/1781 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/1781is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

514.4M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/1781

In the news

Latest news · TPEX/1781

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-17.3

P25 -16.2P50 0.3P75 9.8

ROIC-22.2

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/1781 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

191

Groups with data

Currency

TWD

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 463.6M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Devices
Isin	TW0001781003
Last refreshed	2026-05-10
Market cap	TWD 514.4M
Price	TWD 10.85
Price currency	TWD
Sector	Healthcare
Sic	3841
Symbol	tpex/1781
Website	https://www.healthandlife.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.99%
EV Earnings	-7.52x
EV/FCF	-123.95x
EV/Sales	1.16x
FCF yield	-0.73%
P/B ratio	1.6x
P/S ratio	1.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-15.93%
EBITDA Margin	-13.3%
Gross margin	17.62%
Gross Profit	TWD 70.1M
Gross Profit Growth	-52.54%
Gross Profit Growth Q	-68.5%
Gross Profit Growth3 Y	-10.48%
Gross Profit Growth5 Y	-11.21%
Net Income	TWD -61.7M
Net Income Growth Years	0%
Pretax Margin	-16.92%
Profit Margin	-15.49%
ROA	-5.15
Roa5y	-3.73
ROCE	-12.28
ROE	-17.28
Roe5y	-7.98
ROIC	-22.17
Roic5y	-16.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-5.65%
Cagr15y	-6.37%
Cagr1y	-20.23%
Cagr20y	-3.13%
Cagr3y	-10.13%
Cagr5y	-12.16%
EPS Growth Years	0
FCF Growth Q	-63.61%
OCF Growth	-90.47%
OCF Growth Q	-61.88%
OCF Growth10 Y	-22.53%
Revenue Growth	-43.65x
Revenue Growth Q	-27.19x
Revenue Growth Years	0x
Revenue Growth3 Y	-20.68x
Revenue Growth5 Y	-12.46x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.52
Assets	TWD 723.1M
Cash	TWD 247.6M
Current Assets	TWD 494.1M
Current Liabilities	TWD 206.7M
Debt	TWD 196.8M
Debt Equity	TWD 0.61
Debt FCF	TWD -52.63
Equity	TWD 320.6M
Interest Coverage	-10.61
Liabilities	TWD 402.6M
Long Term Assets	TWD 229M
Long Term Liabilities	TWD 195.9M
Net Cash	TWD 50.8M
Net Cash By Market Cap	TWD 9.88
Net Cash Growth	-19.38%
Net Debt Equity	TWD -0.16
Tangible Book Value	TWD 319.5M
Tangible Book Value Per Share	TWD 6.74
WACC	4.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.39
Inventory Turnover	2.63
Net Working Capital	TWD 43.5M
Quick ratio	1.66
Working Capital	TWD 287.4M
Working Capital Turnover	TWD 1.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.96%
Dividend per share	TWD 0
Last Dividend	TWD 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-44.07%
1Y total return	-20.22%
200-day SMA	12.48
3Y total return	-27.42%
50-day SMA	11.85
50-day SMA vs 200-day SMA	50under200
5Y total return	-47.71%
All Time High	161.4
All Time High Change	-93.28%
All Time High Date	2004-06-23
All Time Low	6
All Time Low Change	80.83%
All Time Low Date	2020-03-23
ATR	0.2
Beta	0.25
Beta1y	0.1
Beta2y	0.29
Ch YTD	-1.81
High	10.95
High52	16
High52 Date	2025-06-19
High52ch	-32.19%
Low	10.75
Low52	10.65
Low52 Date	2026-05-07
Low52ch	1.88%
Ma50ch	-8.43%
Price vs 200-day SMA	-13.03%
RSI	31.38
RSI Monthly	38.12
RSI Weekly	31.6
Sharpe ratio	-0.59x
Sortino ratio	-0.77
Total Return	5.96%
Tr YTD	-1.81
Tr15y	-62.72%
Tr1m	-10.7%
Tr1w	0.46%
Tr3m	-14.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -63.4M
Operating margin	-15.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	34,747,973%
Net Borrowing	-21,774,000
Shares Insiders	23.56%
Shares Out	47,407,605
Shares Qo Q	0%
Shares Yo Y	-5.96%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -3.7M
Average Volume	50,474x
Bv Per Share	6.76
CAPEX	TWD -6.9M
Ch10y	-44.07
Ch15y	-63.34
Ch1m	-10.7
Ch1w	0.46
Ch1y	-20.22
Ch20y	-47.95
Ch3m	-14.23
Ch3y	-27.42
Ch5y	-47.71
Ch6m	-10.33
Change	0.93%
Change From Open	0.46
Close	10.75
Days Gap	0.47
Depreciation Amortization	10,462,000
Dollar Volume	369,410
Earnings Date	2026-05-11
EBIT	TWD -63.4M
EBITDA	TWD -52.9M
EPS	TWD -1.3
F Score	3
FCF	TWD -3.7M
FCF EV Yield	-0.81x
FCF Per Share	TWD -0.08
Financing CF	-21,911,000
Fiscal Year End	December
Founded	1,996
Income Tax	TWD -5.7M
Investing CF	41,959,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2006-09-14
Last Split Type	Forward
Ma150	11.97
Ma150ch	-9.35%
Ma20	11.19
Ma20ch	-3.04%
Net CF	20,625,000
Next Earnings Date	2026-05-11
Open	10.8
P OCF Ratio	161.5
Position In Range	50
Ppne	141,911,000
Price Date	2026-05-08
Ptbv Ratio	1.61
Relative Volume	0.68x
Revenue	398,046,000x
Tax By Revenue	-1.43x
Tr20y	-47.06%
Tr6m	-10.33%
Volume	34,047
Z Score	1.49

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/1781 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/1781 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/1781?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+23.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-6.0%

Negative means the company is buying back shares.

Technical

TPEX/1781 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.4

Neutral momentum band

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/1781

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/1781 stock rating?

tpex/1781 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/1781 analysis?

The full report lives at /stocks/tpex/1781/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/1781?

The latest report frames tpex/1781 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/1781 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.